Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis
Crossref DOI link: https://doi.org/10.1007/s11239-014-1104-3
Published Online: 2014-06-28
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rognoni, Carla
Marchetti, Monia
Quaglini, Silvana
Liberato, Nicola Lucio
Text and Data Mining valid from 2014-06-28